LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic Nephropathy

BackgroundDiabetic nephropathy (DN) is a serious complication among patients with diabetes. Elucidating its pathogenesis is crucial for identifying novel biomarkers and therapeutic targets for DN.MethodsDN tissues were harvested for examining MALAT1, LIN28A and Nox4. Human kidney-2 (HK-2) cells were...

Full description

Bibliographic Details
Main Authors: Panai Song, Yinyin Chen, Zhiwen Liu, Hong Liu, Li Xiao, Lin Sun, Jiali Wei, Liyu He
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.895360/full
_version_ 1811241384416378880
author Panai Song
Panai Song
Yinyin Chen
Zhiwen Liu
Zhiwen Liu
Hong Liu
Hong Liu
Li Xiao
Li Xiao
Lin Sun
Lin Sun
Jiali Wei
Liyu He
Liyu He
author_facet Panai Song
Panai Song
Yinyin Chen
Zhiwen Liu
Zhiwen Liu
Hong Liu
Hong Liu
Li Xiao
Li Xiao
Lin Sun
Lin Sun
Jiali Wei
Liyu He
Liyu He
author_sort Panai Song
collection DOAJ
description BackgroundDiabetic nephropathy (DN) is a serious complication among patients with diabetes. Elucidating its pathogenesis is crucial for identifying novel biomarkers and therapeutic targets for DN.MethodsDN tissues were harvested for examining MALAT1, LIN28A and Nox4. Human kidney-2 (HK-2) cells were treated with high glucose (HG) for establishing a cell model of DN. Cell viability was examined by MTT assay. HG-induced cell apoptosis and secretion of TNF-α and IL-6 were analyzed by TUNEL and ELISA assays, respectively. RIP and RNA pull-down assays were applied to analyze the interaction between MALAT1, LIN28A and Nox4 in HK-2 and human embryonic kidney 293T (HEK-293T) cells. A rat model of DN was established to determine the role of MALAT1 in DN in vivo.ResultsMALAT1, LIN28A and Nox4 were upregulated in DN tissues and HG-treated HK-2 cells. Overexpression of MALAT1, LIN28A or Nox4 reduced cell viability and enhanced cell apoptosis, ROS generation and secretion of inflammatory cytokines in HG-treated HK-2 cells, whereas knockdown of MALAT1, LIN28A or Nox4 exerted opposite effects. Furthermore, MALAT1 directly interacted with LIN28A. Moreover, MALAT1 facilitated the interaction between LIN28A and Nox4 to increase Nox4 stability. Knockdown of Nox4 relieved HG-induced injury by suppressing the AMPK/mTOR signaling in HK-2 cells. Knockdown of MALAT1 alleviated renal tubular epithelial injury by suppressing LIN28A and the Nox4/AMPK/TOR signaling in DN.ConclusionMALAT1 activates the AMPK/mTOR signaling via interacting with LIN28A to stabilize Nox4 mRNA, thereby aggravating high glucose-induced renal tubular epithelial injury. Our findings provide potential therapeutic targets for DN.
first_indexed 2024-04-12T13:35:23Z
format Article
id doaj.art-4bdf6a603b974da8a4a5032e5e283b38
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-12T13:35:23Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-4bdf6a603b974da8a4a5032e5e283b382022-12-22T03:31:01ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.895360895360LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic NephropathyPanai Song0Panai Song1Yinyin Chen2Zhiwen Liu3Zhiwen Liu4Hong Liu5Hong Liu6Li Xiao7Li Xiao8Lin Sun9Lin Sun10Jiali Wei11Liyu He12Liyu He13Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaHunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, ChinaDepartment of Nephrology, Hunan Provincial People’s Hospital, Changsha, ChinaDepartment of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaHunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, ChinaDepartment of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaHunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, ChinaDepartment of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaHunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, ChinaDepartment of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaHunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, ChinaDepartment of Nephrology, Hainan General Hospital, Haiko, ChinaDepartment of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaHunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, ChinaBackgroundDiabetic nephropathy (DN) is a serious complication among patients with diabetes. Elucidating its pathogenesis is crucial for identifying novel biomarkers and therapeutic targets for DN.MethodsDN tissues were harvested for examining MALAT1, LIN28A and Nox4. Human kidney-2 (HK-2) cells were treated with high glucose (HG) for establishing a cell model of DN. Cell viability was examined by MTT assay. HG-induced cell apoptosis and secretion of TNF-α and IL-6 were analyzed by TUNEL and ELISA assays, respectively. RIP and RNA pull-down assays were applied to analyze the interaction between MALAT1, LIN28A and Nox4 in HK-2 and human embryonic kidney 293T (HEK-293T) cells. A rat model of DN was established to determine the role of MALAT1 in DN in vivo.ResultsMALAT1, LIN28A and Nox4 were upregulated in DN tissues and HG-treated HK-2 cells. Overexpression of MALAT1, LIN28A or Nox4 reduced cell viability and enhanced cell apoptosis, ROS generation and secretion of inflammatory cytokines in HG-treated HK-2 cells, whereas knockdown of MALAT1, LIN28A or Nox4 exerted opposite effects. Furthermore, MALAT1 directly interacted with LIN28A. Moreover, MALAT1 facilitated the interaction between LIN28A and Nox4 to increase Nox4 stability. Knockdown of Nox4 relieved HG-induced injury by suppressing the AMPK/mTOR signaling in HK-2 cells. Knockdown of MALAT1 alleviated renal tubular epithelial injury by suppressing LIN28A and the Nox4/AMPK/TOR signaling in DN.ConclusionMALAT1 activates the AMPK/mTOR signaling via interacting with LIN28A to stabilize Nox4 mRNA, thereby aggravating high glucose-induced renal tubular epithelial injury. Our findings provide potential therapeutic targets for DN.https://www.frontiersin.org/articles/10.3389/fendo.2022.895360/fullLIN28Adiabetic nephropathyrenal tubular injuryAMPK/mTOR signalingMALAT1
spellingShingle Panai Song
Panai Song
Yinyin Chen
Zhiwen Liu
Zhiwen Liu
Hong Liu
Hong Liu
Li Xiao
Li Xiao
Lin Sun
Lin Sun
Jiali Wei
Liyu He
Liyu He
LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic Nephropathy
Frontiers in Endocrinology
LIN28A
diabetic nephropathy
renal tubular injury
AMPK/mTOR signaling
MALAT1
title LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic Nephropathy
title_full LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic Nephropathy
title_fullStr LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic Nephropathy
title_full_unstemmed LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic Nephropathy
title_short LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic Nephropathy
title_sort lncrna malat1 aggravates renal tubular injury via activating lin28a and the nox4 ampk mtor signaling axis in diabetic nephropathy
topic LIN28A
diabetic nephropathy
renal tubular injury
AMPK/mTOR signaling
MALAT1
url https://www.frontiersin.org/articles/10.3389/fendo.2022.895360/full
work_keys_str_mv AT panaisong lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT panaisong lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT yinyinchen lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT zhiwenliu lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT zhiwenliu lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT hongliu lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT hongliu lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT lixiao lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT lixiao lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT linsun lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT linsun lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT jialiwei lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT liyuhe lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy
AT liyuhe lncrnamalat1aggravatesrenaltubularinjuryviaactivatinglin28aandthenox4ampkmtorsignalingaxisindiabeticnephropathy